Abstract
Over the years a number of ways to overcome the discrepancy between the need and the availability of lungs for transplantation have been explored, including the use of lung allocation scores and the implementation of standardized donor management protocols. In the last decade several authors have extended lung donor criteria to increase the pool of organs, unfortunately with controversial results. However, the available evidence in favor or against the commonly used lung donor selection criteria leaves a large number of uncertainties in the lung donation process.
Recently, the feasibility and safety of transplanting high-risk donor lungs that have undergone ex vivo lung perfusion (EVLP) have been successfully documented. EVLP allows to evaluate before transplantation donor lungs the function of which is doubtful and to recondition injured donor lungs, thus increasing the number of organs available for transplantation This possibility has brought a new paradigm in the selection of lungs suitable for transplantation.
Ex vivo lung perfusion to recondition donor lungs before transplantation has a number of advantages and, as an emerging innovative technique, has opened a new field of research in the transplantation community.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Aigner C, Slama A, Hotzenecker K et al (2012) Clinical ex vivo lung perfusion–pushing the limits. Am J Transplant 12:1839–1847
Avlonitis VS, Fisher AJ, Kirby JA et al (2003) Pulmonary transplantation: the role of brain death in donor lung injury. Transplantation 75:1928–1933
Cypel M, Rubacha M, Yeung J et al (2009) Normothermic ex vivo perfusion prevents lung injury compared to extended cold preservation for transplantation. Am J Transplant 9:2262–2269
Cypel M, Yeung JC, Liu M et al (2011) Normothermic ex vivo lung perfusion in clinical lung transplantation. N Engl J Med 364:1431–1440
Cypel M, Yeung JC, Machuca T et al (2012) Experience with the first 50 ex vivo lung perfusions in clinical transplantation. J Thorac Cardiovasc Surg 144:1200–1206
de Perrot M, Snell GI, Babcock WD et al (2004) Strategies to optimize the use of currently available lung donors. J Heart Lung Transplant 23:1127–1134
Egan TM, Murray S, Bustami RT et al (2006) Development of the new lung allocation system in the United States. Am J Transplant 6:1212–1227
Ingemansson R, Eyjolfsson A, Mared L et al (2009) Clinical transplantation of initially rejected donor lungs after reconditioning ex vivo. Ann Thorac Surg 87:255–260
Jirsch DW, Fisk RL, Couves CM (1970) Ex vivo evaluation of stored lungs. Ann Thorac Surg 10:163–168
Lee JW, Fang X, Gupta N et al (2009) Allogeneic human mesenchymal stem cells for treatment of E. coli endotoxin-induced acute lung injury in the ex vivo perfused human lung. Proc Natl Acad Sci U S A 106:16357–16362
Martins S, de Perrot M, Imai Y et al (2004) Transbronchial administration of adenoviral-mediated interleukin-10 gene to the donor improves function in a pig lung transplant model. Gene Ther 11:1786–1796
Oto T, Levvey BJ, Whitford H et al (2007) Feasibility and utility of a lung donor score: correlation with early post-transplant outcomes. Ann Thorac Surg 83:257–263
Porro GA, Valenza F, Coppola S et al (2012) Use of the Oto lung donor score to analyze the 2010 donor pool of the Nord Italia Transplant program. Transplant Proc 44:1830–1834
Snell GI, Paraskeva M, Westall GP (2013) Donor selection and management. Semin Respir Crit Care Med 34:361–370
Steen S, Ingemansson R, Eriksson L et al (2007) First human transplantation of a nonacceptable donor lung after reconditioning ex vivo. Ann Thorac Surg 83:2191–2194
Steen S, Sjoberg T, Pierre L et al (2001) Transplantation of lungs from a non-heart-beating donor. Lancet 357:825–829
Valenza F, Rosso L, Coppola S et al (2012) beta-adrenergic agonist infusion during extracorporeal lung perfusion: effects on glucose concentration in the perfusion fluid and on lung function. J Heart Lung Transplant 31:524–530
Van Raemdonck D, Neyrinck A, Verleden GM et al (2009) Lung donor selection and management. Proc Am Thorac Soc 6:28–38
Venkateswaran RV, Dronavalli V, Patchell V et al (2013) Measurement of extravascular lung water following human brain death: implications for lung donor assessment and transplantation. Eur J Cardiothorac Surg 43:1227–1232
Wallinder A, Ricksten SE, Hansson C et al (2012) Transplantation of initially rejected donor lungs after ex vivo lung perfusion. J Thorac Cardiovasc Surg 144:1222–1228
Wallinder A, Ricksten SE, Silverborn M et al (2014) Early results in transplantation of initially rejected donor lungs after ex vivo lung perfusion: a case-control study. Eur J Cardiothorac Surg 45:40–44
Zych B, Popov AF, Stavri G et al (2012) Early outcomes of bilateral sequential single lung transplantation after ex-vivo lung evaluation and reconditioning. J Heart Lung Transplant 31:274–281
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2014 Springer-Verlag Italia
About this chapter
Cite this chapter
Valenza, F., Fumagalli, J., Salice, V., Gattinoni, L. (2014). Lung Reconditioning. In: Sangalli, F., Patroniti, N., Pesenti, A. (eds) ECMO-Extracorporeal Life Support in Adults. Springer, Milano. https://doi.org/10.1007/978-88-470-5427-1_29
Download citation
DOI: https://doi.org/10.1007/978-88-470-5427-1_29
Published:
Publisher Name: Springer, Milano
Print ISBN: 978-88-470-5426-4
Online ISBN: 978-88-470-5427-1
eBook Packages: MedicineMedicine (R0)